Declaration of competing financial interests : Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction : Nature Reviews Drug Discovery

Jump to main content
Jump to navigation
nature.com homepage
Publications A-Z index
Browse by subject

My account
E-alert sign up
Register
Subscribe

From the following article:

Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction

Jarl E. S. Wikberg & Felikss Mutulis

Nature Reviews Drug Discovery 7, 307-323 (April 2008)

doi:10.1038/nrd2331

Declaration: J.E.S.W. holds a grant from the Swedish Research Council for studies on melanocortin receptors; holds shares in Genetta Soft AB, a Swedish company devoted to bioinformatics software; and is author of patents related to melancocortin receptors. F.M. has no competing financial interests.